Company profile
Scribe Therapeutics, Inc. Insider Trading
SCTXEvery SEC Form 4 insider trading filing for Scribe Therapeutics, Inc. (SCTX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001853921
- Filings
- 13
- Insiders
- 19
- Last filing
- 2026-07-28
Activity summary
No insider transactions in the last 30 days. The most recent was on July 28, 2026, when Behzad Aghazadeh bought 7,905 shares. 13 filings from 19 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q1 26 to Q3 26. Scribe Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $71.3M.
90 day insight
Over the last 90 days, Scribe Therapeutics, Inc. insiders bought $71.3M across 21 transactions with no open-market sales.
- Most active insider: AH Bio Fund II, L.P. with 5 transactions totaling $5.0M.
- Largest single purchase: $35.0M by Behzad Aghazadeh on Jul 24, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Behzad Aghazadeh | SCTX | Purchase | 7,905 | $18.25 | $144K |
| Jul 27, 2026 | AH Bio Fund II, L.P. | SCTX | C | 4,131,344 | — | — |
| Jul 27, 2026 | AH Bio Fund II, L.P. | SCTX | C | 12,150,003 | — | — |
| Jul 27, 2026 | AH Bio Fund II, L.P. | SCTX | Purchase | 333,333 | $15.00 | $5.00M |
| Jul 27, 2026 | AH Bio Fund II, L.P. | SCTX | C | 2,051,742 | — | — |
30 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=SCTX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.